Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion type Assertion NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_head.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion description "[The presence of COX-2 expression in PJS carcinomas and dysplastic hamartomas provides a rationale for chemoprevention with nonsteroidal anti-inflammatory drugs or COX-2 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion evidence source_evidence_literature NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion SIO_000772 12912958 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion wasDerivedFrom befree-20150227 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion wasGeneratedBy ECO_0000203 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.